Study 3: Wessells 1998, erectogenic effect Citation: Wessells H., Fuciarelli K., Hansen J., et al
Of note, even before the introduction of the newer classes of medications, multifactorial, target-driven therapies addressing glycaemic, blood pressure and lipid control that incorporated reninangiotensin system blockade, the use of statins and attention to lifestyle factors significantly reduced the progression to end-stage kidney disease by about 50% in people with type 2 diabetes, hypertension and microalbuminuria
Download MeAgain and turn your health journey into a game worth playing
Always check the vial before using
A parallel programme, REIMAGINE, is evaluating CagriSema specifically in type 2 diabetes
the hormone that helps control hunger, insulin levels, and digestion speed